Precipio, Inc. cotiza a 22.59 USD y tiene una capitalización bursátil de $40M. En los últimos 12 meses ha facturado $27M con un margen de flujo de caja libre del 1.5%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enabl…
| Periodo | 2023-11 | 2023-08 | 2023-05 | 2023-03 |
|---|---|---|---|---|
| Real | $-1.04 | $-1.80 | $-2.60 | $-2.00 |
| Estimado | $-1.40 | $-2.00 | $-2.60 | $-2.80 |
| Sorpresa | +25.7% | +10.0% | +0.0% | +28.6% |
| Métrica | PRPO | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 44.5% | 57.0% | -12.5% |
| Operating Margin | -5.0% | -38.6% | +33.6% |
| Net Margin | -1.5% | -33.6% | +32.1% |
| FCF Margin | 1.5% | -13.9% | +15.3% |
| ROE | -2.5% | -40.4% | +37.9% |
| ROA | -1.7% | -32.0% | +30.3% |
| Current Ratio | 1.61 | 2.84 | -1.23 |
| Debt / Equity | 0.01 | 0.28 | -0.27 |